Ingredient or product comparison
GHK-Cu Stays in System: Clearance Comparison Across Peptide Classes
Understanding how long GHK-Cu stays in system becomes clearer when compared against other research peptides with similar molecular weights but different stability profiles and receptor interactions. GHK-Cu 25–35 minutes 24–72 hours (tissue-bound) Renal filtrat
This source-based comparison does not add ratings or recommend a winner.
- Understanding how long GHK-Cu stays in system becomes clearer when compared against other research peptides with similar molecular weights but different stability profiles and receptor interactions.
- GHK-Cu
- 25–35 minutes
- 24–72 hours (tissue-bound)
- Renal filtration, peptidase degradation
- High affinity for extracellular matrix (collagen, fibronectin, heparan sulfate)
- Clears from serum rapidly but tissue-binding extends biological effects well beyond measurable plasma presence. Dose every 24–48 hours based on tissue turnover, not serum half-life
- BPC-157
- 4–6 hours
- 12–24 hours
- Renal filtration, enzymatic hydrolysis
- Moderate binding to gastric mucosa and endothelial cells
- Longer plasma presence than GHK-Cu due to partial resistance to peptidases; systemic effects align more closely with serum levels. Dose 1–2× daily
- Thymosin Beta-4 (TB-500)
- 2–3 hours
- 48–96 hours
- Renal excretion, intracellular sequestration
- Binds intracellularly to G-actin, altering cytoskeletal dynamics
- Rapid serum clearance but intracellular sequestration and slow release from actin-binding sites produces multi-day effects. Dose 1–2× weekly
- Melanotan II
- 33 minutes
- 6–12 hours
- Renal filtration
- Binds melanocortin receptors (MC1R, MC4R) with high affinity but rapid internalization and degradation
- Short half-life, short effect duration. Receptor-mediated effects terminate quickly once ligand is cleared. Dose daily or every other day
- Ipamorelin
- 1.5–2 hours
- 2–4 hours
- Renal excretion
- Selective ghrelin receptor (GHSR1a) agonist, rapid receptor internalization
- Short half-life, short functional window. Growth hormone release occurs within 30–60 minutes, then activity ceases. Dose 2–3× daily for sustained signaling
- The table reveals a critical distinction: peptides with intracellular or matrix-binding mechanisms (GHK-Cu, TB-500) show pronounced separation between serum half-life and effect duration, while receptor agonists (Ipamorelin, Melanotan II) exhibit tighter coupling. When the peptide leaves circulation, receptor activation stops. GHK-Cu's mechanism is not receptor-mediated in the classical sense; it modulates gene expression via copper delivery to enzyme active sites and direct interaction with chromatin-remodeling complexes. Those changes persist after the peptide itself has been degraded.